Femasys (FEMY) Notes Payables (2020 - 2025)

Femasys (FEMY) reported Notes Payables of $276489.0 for Q3 2025, down 95.45% quarter-over-quarter from $6.1 million in Q2 2025.

Femasys (FEMY) Notes Payables (2020 - 2025) Analysis & Trends

Femasys has reported Notes Payables for 6 years, with the latest figure at $276489.0 in Q3 2025.

For the quarter ending Q3 2025, Notes Payables changed N/A year-over-year to $276489.0; the trailing twelve-month figure through Sep 2025 stood at $276489.0 (changed N/A YoY), and the FY2024 full-year result was $5.4 million, changed N/A from the prior year.
Notes Payables for Q3 2025 stood at $276489.0, down from $6.1 million in the prior quarter.
The five-year high for Notes Payables was $6.1 million in Q2 2025, with the low at $45666.0 in Q1 2022.
Historically, Notes Payables has averaged $1.6 million across 5 years, with a median of $302100.0 in 2021.
Annual changes were most pronounced in 2021 — Notes Payables plunged 71.25% — and 2023, when it advanced 0.98%.
Femasys' Notes Payables stood at $181123.0 in 2021, then retreated by 21.99% to $141298.0 in 2022, then soared by 100.52% to $283334.0 in 2023, then jumped by 1808.08% to $5.4 million in 2024, then slumped by 94.89% to $276489.0 in 2025.
The last three Notes Payables figures came in at $276489.0 (Q3 2025), $6.1 million (Q2 2025), and $5.8 million (Q1 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Femasys	254.59 Mn	249.20 Mn	-

Download Data